Fig. 19

Active site residues & drug binding motifs of NSP16. a–c Different surface projections showing inhibitory association of drug binding motifs with active site residues of the enzyme. 478-Amprenavir; 017-Darunavir; RIM Rimantadine, ROC Saquinavir